Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Setmelanotide is approved for chronic weight management in patients with POMC, PCSK1, LEPR deficiencies and Bardet–Biedl syndrome by reducing hunger and promoting weight loss92, TB-500 is studied for enhancing musculoskeletal and cardiac repair, wound healing, and promoting cell migration and differentiation via actin cytoskeleton remodeling21255.
While Setmelanotide works as a potent synthetic melanocortin-4 receptor (MC4R) agonist derived from a POMC/α-MSH–related sequence that restores downstream MC4R signaling in genetic obesity syndromes3192100, TB-500 is a synthetic peptide comprising the LKKTETQ actin-binding motif of thymosin beta-4 that binds G-actin, sequesters actin monomers, and promotes cell migration, angiogenesis, and tissue repair1255.
Setmelanotide
POMC
TB-500
TMSB4X
Setmelanotide and TB-500 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Setmelanotide is more often discussed in the realm of Metabolic and endocrine, whereas TB-500 is more often associated with the realm of Musculoskeletal health and Cardiovascular health. Their biological logic is quite different: Setmelanotide is a receptor agonist, whereas TB-500 is a signaling modulator and a growth factor mimetic. Setmelanotide has a more synthetic design origin, while TB-500 is closer to synthetic analog background and their development context also differs, with Setmelanotide approved while TB-500 is in Preclinical development. Setmelanotide takes the form of a cyclic peptide, whereas TB-500 is closer to a linear peptide, while Setmelanotide incorporates d-amino acid substitution features that are not part of TB-500.